Salim S. Abdool Karim, MD, PhD, is a clinical infectious diseases epidemiologist whose research interests are in microbicides and vaccines to prevent HIV infection, as well as implementing antiretroviral therapy in resource constrained settings. In addition to his faculty position as professor of clinical Epidemiology at the Mailman School, he is pro vice-chancellor (Research), University of KwaZulu-Natal and Director of CAPRISA - Centre for the AIDS Program of Research in South Africa. Dr. Abdool Karim recently led the NIH-funded HPTN 035 microbicide trial which revealed the potential of anionic polymer, PRO2000, in preventing HIV infection in women. His clinical research on TB-HIV treatment has impacted and continues to shape the clinical management of co-infected patients. He has published widely on infectious diseases, including HIV/AIDS, measles and hepatitis B, and co-edited the textbook that is used extensively to teach epidemiology in South Africa. Dr. Abdool Karim is chair of the WHO Scientific Advisory Group for Reproductive Health and is a member of the WHO Expert Advisory Panel on Sexually Transmitted Infections and HIV. View Faculty CV here (PDF).